Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
0.860
-0.040 (-4.49%)
Apr 29, 2026, 9:35 AM EDT - Market open

Oncolytics Biotech Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-28.76-22.79-21.01-18.35-20.79
Upgrade
Depreciation & Amortization
0.070.090.310.290.36
Upgrade
Stock-Based Compensation
6.571.981.571.763.02
Upgrade
Other Operating Activities
0.83-1.68-3.73-1.240.4
Upgrade
Change in Accounts Receivable
0-0.040.380.25-0.61
Upgrade
Change in Accounts Payable
2.930-0.061.230.14
Upgrade
Change in Other Net Operating Assets
-1.762.561.01-1.19-0.25
Upgrade
Operating Cash Flow
-20.11-19.88-21.54-17.26-17.73
Upgrade
Capital Expenditures
-0.01-0.17-0.01-0.04-0.23
Upgrade
Investment in Securities
--15.32-15.03-
Upgrade
Investing Cash Flow
-0.01-0.1715.31-15.08-0.23
Upgrade
Long-Term Debt Repaid
---0.31-0.28-0.29
Upgrade
Net Debt Issued (Repaid)
---0.31-0.28-0.29
Upgrade
Issuance of Common Stock
14.915.0324.539.8627.37
Upgrade
Other Financing Activities
-0.79---0.56-0.99
Upgrade
Financing Cash Flow
14.125.0324.239.0226.09
Upgrade
Foreign Exchange Rate Adjustments
0.12-0.29-0.41.45-0.2
Upgrade
Net Cash Flow
-5.88-15.3217.6-21.877.94
Upgrade
Free Cash Flow
-20.12-20.06-21.55-17.3-17.95
Upgrade
Free Cash Flow Per Share
-0.21-0.26-0.32-0.30-0.34
Upgrade
Cash Income Tax Paid
0.070.130.090.030.03
Upgrade
Levered Free Cash Flow
-10.38-11.33-13.74-9.37-10.74
Upgrade
Unlevered Free Cash Flow
-10.38-11.33-13.74-9.37-10.74
Upgrade
Change in Working Capital
1.182.521.340.29-0.72
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.